Treatment Advances in Digestive Diseases

Helicobacter pylori (H. pylori) infection is a typical infection which is the major cause of peptic ulcer disease and gastric cancer. Most people with H. pylori infection will never have any signs or symptoms. Diagnosis of this disease can be done using blood test, breath test, stool test, scope test. Treatment can be done using Proton pump inhibitors, Histamine (H-2) blockers, Bismuth subsalicylate.

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs and their widespread use is associated with increased gastro-intestinal toxic effects such as ulceration, haemorrhage, perforation and death.

Using of Lansoprazole in the prophylaxis of acid aspiration during elective surgery is one the advance treatment in Digestive diseases.

  • Helicobacter Pylori Treatment
  • Nonsteroidal anti-inflammatory drugs
  • Proton-pump inhibitors
  • Prophylaxis with Lansoprazole

Related Conference of Treatment Advances in Digestive Diseases

July 08-09-2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

2nd World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia
October 23-24, 2019

World Congress on Pancreatic Cancer and Liver Diseases

| Tokyo, Japan
October 29-30, 2019

World conference on Digestive and Metabolic diseases

Berlin, Germany
November 18-19, 2019

20th World Congress on Gastroenterology

Rome, Italy
March 15-16, 2020

7th World Congress on Hepatitis & Liver Diseases

Osaka, Japan

Treatment Advances in Digestive Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in